Courtesy of MGK
MINNEAPOLIS, Minn. – MGK announced the U.S. Environmental Protection Agency (EPA) registration of its newest active ingredient, Veratrine.
This development marks an important milestone in MGK’s ongoing commitment to efficacious pest control solutions by adding a new mode of action to the company’s botanical portfolio, the company said.
Veratrine is a botanical active ingredient comprised of alkaloids extracted from the seed of the sabadilla plant (Schoenocaulon officinale). Sabadilla alkaloids have unique insecticidal properties to control a wide range of pests.
One of the key benefits of Veratrine is a Mode of Action (IRAC class “UNE”) that is unique from other botanical or conventional insect control options, the company said. The registration of Veratrine resulted from MGK’s R&D efforts and collaboration across technical, regulatory and commercial teams.
“This is an exciting moment for MGK,” said Steve Gullickson, President and CEO. “We couldn’t be more proud of our team for their hard work and creativity in making Veratrine a reality. This new active ingredient is a significant step forward in our commitment to provide pest control solutions that make a real difference for our customers and the communities they serve.”
Veratrine is designed to support a broad range of pest management applications across MGK’s key market segments. Specific formulations are currently under development to bring new botanical solutions with a unique mode of action into professional pest control, animal production, vector control and crop protection markets.
Latest from Pest Control Technology
- Earn CEUs from Your State at Next Week’s Mosquito Control Virtual Conference
- Preserving Culture, Providing Opportunities Key in Hoffman’s Decision
- Winter Weather Could Decide How Bad Mosquito Season Gets
- Trent Frazer Discusses How Mosquitoes Survive Winter
- Barnes Exterminating Acquires Tennessee Pest Solutions
- Pest Index Up 9% YOY in January
- Arrow Exterminators Acquires Hoffman's Exterminating
- PMPs Plan Mera Peak Summit for Parkinson's